Trial Limitations

Benefits

Risks & contraindications

Other

Highlighted claims

• The open-label design introduces an inherent risk of performance bias because participants and physiotherapists cannot be blinded to allocation. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• A limitation is that pelvic floor physiotherapy interventions are not fully standardised across techniques, session content, and quality. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• The study addresses PFPT variability by restricting treatment to physiotherapists with specific pelvic floor expertise in dedicated Metro South Health pelvic floor units. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• Performance bias is partially mitigated by blinding the treating surgeon who diagnoses recurrent diverticulitis to group assignment. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• The study design is described as practical and reproducible. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol
• The multicentre structure is described as increasing generalisability relative to a single-site design. — Pilot multicentre open-label randomised controlled trial assessing prevention of recurrent DIverticulitis through the use of pelvic floor PHYSIOtherapy: DIPHYSIO study protocol